Rumour has it Karan Johar secretly flew to South Korea multiple times to get… his face insured. Yup, inspired by a close friend, and apparently it’s a trend there. Insiders say he’s been way more ...

Researchers at the University of Toronto have found GLP-1 weight loss and diabetes drugs like Ozempic and Mounjaro double the ...

Under rules set by the UK's Medicines and Healthcare products Regulatory Agency (MHRA) there are strict criteria any patient should meet before being prescribed Ozempic, Wegovy or Mounjaro, including ...

Demand for cosmetic procedures to fix Sydneysiders’ saggy skin and lost facial fat associated with weight-loss drugs has ...

Omada is trading publicly after 14 years of providing support to patients with weight-related chronic illnesses. Leadership sees the current moment as the perfect time for an IPO, as GLP-1 drugs such ...

The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...

A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.

The UK's MHRA have issued a warning to people on birth control who may also be taking drugs like Ozempic, Wegovy or Mounjaro ...

The petition, filed by Massachusetts, New York, California, and New Jersey, aims to compel the FDA to recognize that mifepristone is safe and effective. More reproductive health news includes GLP-1 ...

Omada Health is making its public-market debut, propelled by Americans’ renewed focus on how weight affects physical health.

U.K. regulators issued guidance on Thursday, warning weight loss and diabetes medications may weaken the effectiveness of ...